All of the following conditions are associated with hyperthyroidism, except?
A patient presents with hyperphosphatemia, "sho" metacarpals, and cataracts. What is the most likely diagnosis?
Which of the following is NOT a recommended site for insulin administration?
A 52-year-old woman presents with palpitations, sweating, and heat intolerance. Physical examination reveals a palpable mass over the anterior aspect of the neck. Which of the following features is most associated with this condition?
Pheochromocytoma is a tumor of which of the following?
Which of the following can cause osteonecrosis?
A 70-year-old male presented with severe confusion, shortness of breath, and obtundation. Lab findings revealed moderately raised serum calcium, mildly raised serum creatinine, mildly raised BUN, normal PTH, elevated PTHrP, and an abnormal chest x-ray. Which of the following drugs can be given for the treatment of hypercalcemia?
A patient presents with thyrotoxicosis and exophthalmos. What would thyroid function tests reveal?
Which of the following is NOT true regarding Cushing syndrome?
Intractable peptic ulceration with renal stones occurs in which condition?
Explanation: The correct answer is **A. Hashimoto’s thyroiditis**. **1. Why Hashimoto’s thyroiditis is the correct answer:** Hashimoto’s thyroiditis is the most common cause of **hypothyroidism** in iodine-sufficient regions. It is an autoimmune destruction of the thyroid gland mediated by T-cells and anti-thyroid peroxidase (anti-TPO) antibodies. While a transient "Hashitoxicosis" can occur early in the disease due to the leakage of preformed hormones from damaged follicles, the definitive clinical state is chronic hypothyroidism. **2. Analysis of incorrect options:** * **Graves’ Disease:** The most common cause of hyperthyroidism. It involves Type II hypersensitivity where thyroid-stimulating immunoglobulins (TSI) bind to and activate the TSH receptor, causing excessive hormone synthesis [1]. * **Toxic Multinodular Goiter (Plummer Disease):** Characterized by focal patches of thyroid autonomy. These nodules function independently of TSH stimulation, leading to hyperthyroidism (usually in older adults). * **Struma Ovarii:** A rare form of monodermal teratoma where ovarian tissue contains >50% thyroid tissue. If this ectopic tissue becomes overactive, it causes hyperthyroidism without thyroid gland enlargement (low iodine uptake in the neck, high uptake in the pelvis). **Clinical Pearls for NEET-PG:** * **Jod-Basedow Phenomenon:** Iodine-induced hyperthyroidism (often after IV contrast or Amiodarone). * **Wolff-Chaikoff Effect:** A transient reduction in thyroid hormone levels caused by the ingestion of a large amount of iodine (the basis for using Lugol’s iodine before surgery). * **Amiodarone:** Can cause both Type 1 (excess iodine) and Type 2 (destructive thyroiditis) thyrotoxicosis, as well as hypothyroidism. * **Diagnosis:** Low TSH with high Free T4/T3 confirms hyperthyroidism. Radioactive Iodine Uptake (RAIU) is **high** in Graves’/TMNG but **low** in thyroiditis and Struma ovarii.
Explanation: ### Explanation **Correct Option: A. Pseudohypoparathyroidism (PHP)** Pseudohypoparathyroidism is a genetic disorder characterized by **end-organ resistance to Parathyroid Hormone (PTH)** [1]. Despite high levels of circulating PTH, the body cannot respond to it, leading to biochemical features of hypoparathyroidism: **hyperphosphatemia** and hypocalcemia [1]. The clinical presentation described—shortened 4th and 5th metacarpals (Archibald’s sign), cataracts (due to chronic hypocalcemia), and often a round face and short stature—is known as **Albright’s Hereditary Osteodystrophy (AHO)** [1]. This phenotype is most classically associated with **PHP Type 1a**, caused by a mutation in the *GNAS1* gene, often exhibiting genetic imprinting [1]. **Why other options are incorrect:** * **B. Hypophosphatasia:** This is a rare genetic disorder characterized by low levels of alkaline phosphatase and defective bone mineralization. It typically presents with **hypophosphatemia** (not hyper) and premature loss of deciduous teeth. * **C. Hyperparathyroidism:** This condition results in **hypophosphatemia** (due to increased renal phosphate excretion) and hypercalcemia, which is the opposite of the biochemical profile described [1]. * **D. Osteomalacia:** Usually caused by Vitamin D deficiency, it presents with **low or normal phosphate** and low calcium [1]. It does not feature the specific skeletal deformities like short metacarpals. **High-Yield Clinical Pearls for NEET-PG:** * **PTH Levels:** In Hypoparathyroidism, PTH is low. In **Pseudohypoparathyroidism**, PTH is **high** (compensatory) [1]. * **Pseudopseudohypoparathyroidism (PPHP):** Patients have the AHO phenotype (short metacarpals, round face) but have **normal** calcium and phosphate levels [1]. * **Archibald’s Sign:** Dimpling over the knuckles of the 4th and 5th metacarpals when making a fist; a classic sign of PHP. * **Basal Ganglia Calcification:** Can also be seen in PHP due to chronic hyperphosphatemia and calcium-phosphate product deposition.
Explanation: Explanation: Insulin must be administered into the **subcutaneous fat** layer to ensure predictable absorption and minimize pain [1]. **Why Option A is correct:** The **dorsum of the hands** is an inappropriate site because it lacks sufficient subcutaneous adipose tissue. Injecting here increases the risk of **intramuscular (IM) injection**, which leads to rapid, unpredictable absorption and severe hypoglycemia [1]. Furthermore, the presence of superficial tendons, nerves, and vessels makes it clinically unsafe. Examination of a patient with diabetes should always include checking insulin injection sites [2]. **Why the other options are incorrect:** * **Abdomen (Option D):** This is the preferred site for insulin administration. It offers the most rapid and consistent absorption rate. Patients are advised to inject at least 2 inches away from the umbilicus. * **Arms (Option B):** The posterior surface (triceps area) of the upper arm is a standard site with moderate absorption speed. * **Lateral Thigh (Option C):** The upper-outer aspect of the thigh is used for slower absorption, which can be beneficial for basal insulin. **High-Yield NEET-PG Pearls:** 1. **Absorption Speed:** Abdomen > Arms > Thighs > Buttocks. 2. **Lipohypertrophy:** Repeated injections in the exact same spot cause fatty lumps that delay insulin absorption. **Site rotation** is the most important preventive measure. 3. **Exercise Effect:** Injecting into a limb that is about to be exercised (e.g., thigh before running) increases blood flow and accelerates insulin absorption, risking hypoglycemia. 4. **Angle of Injection:** Usually 90 degrees with short needles (4-6mm); a 45-degree angle or skin fold may be used in very thin individuals to avoid IM injection [1].
Explanation: ### **Explanation** The clinical presentation of palpitations, sweating, heat intolerance, and a neck mass (goiter) is classic for **Hyperthyroidism**. In a middle-aged woman, the most common cause of hyperthyroidism is **Graves' Disease**, an autoimmune disorder caused by TSH-receptor antibodies (TRAb) [1, 3]. **Why Option C is Correct:** **Ophthalmoplegia** (weakness or paralysis of extraocular muscles) is a hallmark of **Graves' Ophthalmopathy**. This occurs due to the activation of orbital fibroblasts by TSH-receptor antibodies, leading to the accumulation of glycosaminoglycans (GAGs), edema, and fibrosis of the extraocular muscles [2]. This results in proptosis, diplopia, and restricted eye movements. It is specific to Graves' disease and not seen in other causes of thyrotoxicosis [1]. **Why the Other Options are Incorrect:** * **A & D (Constipation and Slow relaxing reflexes):** These are classic features of **Hypothyroidism** [3]. In hyperthyroidism, patients typically experience increased frequency of bowel movements (diarrhea) and **brisk (hyperreflexic)** deep tendon reflexes. * **B (Elevated TSH):** In primary hyperthyroidism (like Graves'), high levels of circulating T3 and T4 exert negative feedback on the pituitary, leading to **suppressed (low) TSH levels** [2]. Elevated TSH with high T4 is rare and suggests a TSH-secreting pituitary adenoma. ### **NEET-PG High-Yield Pearls** * **Graves' Triad:** Hyperthyroidism (Goiter), Ophthalmopathy (Exophthalmos), and Dermopathy (Pretibial Myxedema) [1]. * **Most common muscle involved in Graves' Ophthalmopathy:** Inferior rectus (leading to restricted upward gaze). * **Diagnosis:** Low TSH, High Free T4, and positive **TSH-receptor antibodies (TRAb)** [1, 3]. * **Radioactive Iodine Uptake (RAIU):** Shows **diffuse, increased uptake** in Graves' disease, distinguishing it from thyroiditis (low uptake) [3].
Explanation: **Explanation:** The correct answer is **None of the above** because Pheochromocytoma is a catecholamine-secreting tumor derived from the **chromaffin cells** of the **adrenal medulla**, not the adrenal cortex or other endocrine glands listed. **1. Why the correct answer is "None of the above":** Pheochromocytoma originates from the embryonic neural crest cells. Specifically, it arises from the chromaffin cells of the adrenal medulla (85-90%) or extra-adrenal sympathetic ganglia (10-15%, where they are termed paragangliomas). These cells synthesize and secrete catecholamines (epinephrine and norepinephrine) [4]. **2. Why the other options are incorrect:** * **Adrenal cortex:** This is the outer layer of the adrenal gland derived from mesoderm. It produces steroid hormones: mineralocorticoids (Aldosterone), glucocorticoids (Cortisol), and androgens [2]. Tumors here lead to Conn’s syndrome or Cushing’s syndrome [1]. * **Parathyroids:** These glands regulate calcium homeostasis via Parathyroid Hormone (PTH). Tumors here cause hyperparathyroidism. * **Pituitary:** This gland produces trophic hormones (ACTH, TSH, GH, etc.). While pituitary adenomas are part of MEN 1 syndrome, they are not the site of pheochromocytomas. **High-Yield Clinical Pearls for NEET-PG:** * **The Rule of 10s:** 10% are bilateral, 10% are extra-adrenal, 10% are malignant, and 10% are familial. * **Clinical Triad:** Episodic headache, sweating (diaphoresis), and tachycardia (palpitations). * **Diagnosis:** Best initial screening test is **24-hour urinary fractionated metanephrines** or plasma free metanephrines. Serum chromogranin A may also be elevated [3]. * **Genetic Association:** Associated with **MEN 2A and 2B**, von Hippel-Lindau (VHL) disease, and Neurofibromatosis type 1 (NF1) [3]. * **Management:** Always give **Alpha-blockers first** (e.g., Phenoxybenzamine) before Beta-blockers to avoid a hypertensive crisis caused by unopposed alpha-stimulation.
Explanation: **Explanation:** **Osteonecrosis (Avascular Necrosis)** is the death of bone components due to an interruption of blood supply, most commonly affecting the femoral head. **Why SLE is the Correct Answer:** Systemic Lupus Erythematosus (SLE) is a major risk factor for osteonecrosis. The pathogenesis is multifactorial, involving **vasculitis**, secondary **antiphospholipid syndrome (APLS)** leading to thrombosis, and, most significantly, the chronic use of **high-dose corticosteroids** to manage the disease. In many clinical scenarios, SLE is considered an independent risk factor even when steroid doses are controlled. **Analysis of Other Options:** * **A. Sickle Cell Anemia:** While Sickle Cell Anemia is a classic cause of osteonecrosis (due to vaso-occlusive crises), in the context of this specific question format, SLE is often highlighted as the systemic autoimmune prototype. However, it is important to note that both A and B are technically well-known causes. * **B. Corticosteroid Use:** This is the **most common** non-traumatic cause of osteonecrosis. It induces fat hypertrophy in the marrow, increasing intraosseous pressure and reducing blood flow. * **C. Diabetes Mellitus:** While DM causes various bone pathologies (like Charcot joint), it is **not** a direct or primary cause of osteonecrosis. **NEET-PG High-Yield Pearls:** * **Most common site:** Femoral head (due to retrograde blood supply via the medial circumflex femoral artery). * **Imaging of choice:** **MRI** is the most sensitive investigation for early detection (shows "double line sign"). * **X-ray finding:** "Crescent sign" (subchondral collapse) is a late finding. * **Mnemonic for Causes (PLASTIC RAGS):** **P**ancreatitis, **L**upus (SLE), **A**lcohol, **S**ickle cell, **T**rauma, **I**diopathic, **C**aisson disease, **R**adiation, **A**myloidosis, **G**aucher disease, **S**teroids.
Explanation: ### Explanation **Correct Option: D (Prednisolone)** The clinical presentation (elderly male, confusion, abnormal chest X-ray, elevated PTHrP, and normal PTH) strongly suggests **Humoral Hypercalcemia of Malignancy (HHM)**, likely due to Squamous Cell Carcinoma of the lung [1]. **Why Prednisolone?** In the context of hypercalcemia associated with malignancies (especially lymphomas, multiple myeloma, or certain solid tumors), glucocorticoids like **Prednisolone** are effective. They work by: 1. Decreasing intestinal calcium absorption. 2. Inhibiting bone resorption by decreasing cytokine release. 3. Increasing urinary calcium excretion. *Note: While IV fluids are the immediate first step, among the pharmacological options provided, Prednisolone is a specific treatment for malignancy-associated hypercalcemia.* **Analysis of Incorrect Options:** * **A. Calcitonin:** While it works rapidly to lower calcium by inhibiting osteoclasts, its effect is transient (tachyphylaxis develops within 24–48 hours). It is rarely used as monotherapy. * **B. Furosemide:** Loop diuretics are no longer recommended for routine management unless the patient is in fluid overload. They can worsen dehydration, which is the primary driver of hypercalcemic crisis. * **C. Normal Saline:** This is the **initial** step in management (volume expansion) [1]. However, it is considered "supportive fluid therapy" rather than a "drug" treatment in the context of specific pharmacological management of the underlying cause. **High-Yield Clinical Pearls for NEET-PG:** * **PTHrP (PTH-related protein):** The most common cause of hypercalcemia in non-metastatic solid tumors (e.g., Squamous cell CA of lung, esophagus, or renal cell CA). * **Treatment Hierarchy:** 1. **Immediate:** Aggressive hydration with Normal Saline [1]. 2. **Intermediate:** Calcitonin (for rapid, short-term drop). 3. **Definitve/Long-term:** Bisphosphonates [1] (Zoledronic acid is the drug of choice) or Denosumab. * **Glucocorticoids** are the first-line treatment for hypercalcemia caused by **Vitamin D toxicity**, **Sarcoidosis**, and **Lymphomas** (due to increased 1,25-dihydroxyvitamin D production) [1].
Explanation: **Explanation:** The clinical presentation of **thyrotoxicosis** (excess circulating thyroid hormones) combined with **exophthalmos** (proptosis) is pathognomonic for **Graves' Disease**, the most common cause of hyperthyroidism [3], [4]. **1. Why Option C is Correct:** In Graves' Disease, the body produces Thyroid Stimulating Immunoglobulins (TSI) that bind to and activate the TSH receptors on the thyroid gland [3]. This leads to the autonomous and excessive synthesis and secretion of **T3 and T4**. Through the **negative feedback mechanism**, these high levels of circulating thyroid hormones inhibit the anterior pituitary from secreting Thyroid Stimulating Hormone (TSH) [2]. Therefore, the classic biochemical profile is **elevated T3/T4 with a suppressed (decreased) TSH** [4]. **2. Why Other Options are Incorrect:** * **Option A:** Normal TSH in the presence of high T3/T4 is physiologically inconsistent due to negative feedback, unless there is a rare TSH-secreting pituitary adenoma (Secondary Hyperthyroidism), which does not present with exophthalmos [1]. * **Option B:** This profile (Low T3/T4, High TSH) represents **Primary Hypothyroidism** (e.g., Hashimoto’s Thyroiditis) [1], [2]. * **Option C:** This profile (Low T3, Normal T4, Low TSH) is often seen in **Sick Euthyroid Syndrome**, not thyrotoxicosis. **3. NEET-PG High-Yield Pearls:** * **Exophthalmos:** Specific to Graves' Disease; caused by TSH-receptor antibodies reacting with orbital fibroblasts (not seen in other causes of thyrotoxicosis like toxic multinodular goiter) [3], [4]. * **Best Initial Test:** Serum TSH (most sensitive) [2]. * **T3 Toxicosis:** In early Graves', T3 may rise before T4. * **Wolff-Chaikoff Effect:** Reduction in thyroid hormone levels caused by ingestion of a large amount of iodine.
Explanation: ### Explanation **Cushing Syndrome** is characterized by chronic exposure to excessive levels of glucocorticoids (cortisol). [1] To identify the incorrect statement, one must understand the metabolic and physical effects of cortisol. #### Why Hypoglycemia is the Correct Answer (The "NOT" True Statement) Cortisol is a **counter-regulatory hormone** that opposes the action of insulin. It promotes gluconeogenesis in the liver and decreases glucose uptake in peripheral tissues (muscle and adipose). Therefore, Cushing syndrome leads to **Hyperglycemia** (or impaired glucose tolerance/Diabetes Mellitus), not hypoglycemia. #### Why the Other Options are Incorrect (True Features of Cushing) * **Purplish Striae:** Excess cortisol inhibits fibroblasts and interferes with collagen synthesis, leading to thinning of the skin. [1] When the underlying blood vessels show through the stretched, thin skin, wide (>1 cm) violaceous or purplish striae appear, typically on the abdomen. * **Plethora:** Cortisol causes thinning of the facial skin and may increase red cell mass (polycythemia), resulting in a "facial plethora" or a chronically flushed appearance. * **Obesity:** This is the most common feature. It is specifically **centripetal (central) obesity**, characterized by fat redistribution to the abdomen, mediastinum, and neck ("buffalo hump" and "moon facies"), while the limbs remain thin due to muscle wasting. [1] --- ### NEET-PG High-Yield Clinical Pearls * **Screening Tests:** The best initial tests are the 24-hour urinary free cortisol, late-night salivary cortisol, or the Low-Dose Dexamethasone Suppression Test (LDDST). [2], [3] * **Electrolyte Abnormality:** Severe Cushing (especially ectopic ACTH) often presents with **Hypokalemic Metabolic Alkalosis** due to the mineralocorticoid effects of high cortisol. * **Proximal Myopathy:** Patients often complain of difficulty climbing stairs or rising from a chair due to protein catabolism in the proximal muscles. [1] * **Osteoporosis:** Cortisol decreases bone formation and increases bone resorption, making pathological fractures a known complication.
Explanation: **Explanation:** The correct answer is **MEN I syndrome** (Wermer’s syndrome). This condition is characterized by the "3 Ps": **P**ituitary adenoma, **P**arathyroid hyperplasia/adenoma, and **P**ancreatic islet cell tumors. 1. **Why MEN I is correct:** The patient presents with two distinct pathologies: * **Intractable peptic ulceration:** Caused by a **Gastrinoma** (a pancreatic neuroendocrine tumor), which leads to Zollinger-Ellison Syndrome (ZES). * **Renal stones:** Caused by **Primary Hyperparathyroidism**, which leads to hypercalcemia and hypercalciuria, resulting in nephrolithiasis. The coexistence of these two features specifically points toward the multi-glandular involvement seen in MEN I. 2. **Why other options are incorrect:** * **Zollinger-Ellison Syndrome (A):** While ZES explains the intractable ulcers, it does not inherently cause renal stones unless it is part of MEN I. * **Parathyroid Adenoma (B):** This explains the renal stones (via hypercalcemia) but does not cause intractable peptic ulcers (though hypercalcemia can mildly increase gastrin, it rarely causes "intractable" ulceration). * **Milk-Alkali Syndrome (C):** This presents with the triad of hypercalcemia, metabolic alkalosis, and renal failure due to excessive ingestion of calcium and absorbable alkali. It does not typically cause intractable ulceration. **Clinical Pearls for NEET-PG:** * **MEN I Inheritance:** Autosomal Dominant; mutation in the *MEN1* gene (encoding the protein Menin) on Chromosome 11q13. * **Most common presentation:** Hyperparathyroidism is usually the first clinical manifestation (95% of cases). * **ZES in MEN I:** Gastrinomas in MEN I are often multiple and located in the duodenum rather than the pancreas. * **Screening:** If a patient presents with ZES, always screen for MEN I by checking serum calcium and PTH levels.
Diabetes Mellitus
Practice Questions
Thyroid Disorders
Practice Questions
Adrenal Gland Disorders
Practice Questions
Pituitary Disorders
Practice Questions
Calcium and Bone Metabolism
Practice Questions
Reproductive Endocrinology
Practice Questions
Lipid Disorders
Practice Questions
Endocrine Hypertension
Practice Questions
Multiple Endocrine Neoplasia
Practice Questions
Obesity and Metabolic Syndrome
Practice Questions
Neuroendocrine Tumors
Practice Questions
Endocrine Emergencies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free